drugset / Trial / NCT00511979

Comparison of the Effect on the Glucose Infusion Rates Between Inhaled Technosphere Insulin and a Subcutaneous Injection of Regular Human Insulin

NCT00511979

Phase 1 Completed 12 enrolled Mannkind Corporation
RandomizedCrossoverOpen-labelTreatment

Summary

A prospective, single center, open randomized, six way crossover study comparing the dose response effect of four different doses of Technosphere Insulin after pulmonary function delivery in comparison to s.c. injection of two different doses of regular human insulin.

Timeline

Start
1999-08
Primary completion
2000-02
Completion
2000-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Insulin Protein / enzyme biologic 25 iu Inhaled
Comparator Insulin Protein / enzyme biologic 50 iu Inhaled
Comparator Insulin Protein / enzyme biologic 100 iu Inhaled
Comparator Insulin Protein / enzyme biologic Subcutaneous

Indications

No indication recorded.